These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26097793)

  • 21. Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3-1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects.
    Halstenson CE; Shamp T; Gargano MA; Walsh RM; Patchen ML
    Invest New Drugs; 2016 Apr; 34(2):202-15. PubMed ID: 26865390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen.
    Kaste M; Murayama S; Ford GA; Dippel DW; Walters MR; Tatlisumak T;
    Cerebrovasc Dis; 2013; 36(3):196-204. PubMed ID: 24135530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerability and pharmacokinetics of TB-402 in healthy male volunteers.
    Verhamme P; Pakola S; Jensen TJ; Berggren K; Sonesson E; Saint-Remy JM; Balchen T; Belmans A; Cahillane G; Stassen JM; Peerlinck K; Glazer S; Jacquemin M
    Clin Ther; 2010 Jun; 32(6):1205-20. PubMed ID: 20637972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and safety study of posaconazole intravenous solution administered peripherally to healthy subjects.
    Kersemaekers WM; van Iersel T; Nassander U; O'Mara E; Waskin H; Caceres M; van Iersel ML
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1246-51. PubMed ID: 25512407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post hoc comparison of daily rates of nausea and vomiting with once- and twice-daily galantamine from a double-blind, placebo-controlled, parallel-group, 6-month study.
    Dunbar F; Zhu Y; Brashear HR
    Clin Ther; 2006 Mar; 28(3):365-72. PubMed ID: 16750451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.
    Christopher R; Covington P; Davenport M; Fleck P; Mekki QA; Wann ER; Karim A
    Clin Ther; 2008 Mar; 30(3):513-27. PubMed ID: 18405789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous topiramate: comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers.
    Clark AM; Kriel RL; Leppik IE; Marino SE; Mishra U; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1099-105. PubMed ID: 23506041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why receptor reserve matters for neurokinin1 (NK1) receptor antagonists.
    Trist DG; Ratti E; Bye A
    J Recept Signal Transduct Res; 2013 Dec; 33(6):333-7. PubMed ID: 24106886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralization of alpha(2)-antiplasmin by microplasmin: a randomized, double-blind, placebo-controlled, ascending-dose study in healthy male volunteers.
    Pakola S; Cahillane G; Stassen JM; Lijnen HR; Verhamme P
    Clin Ther; 2009 Aug; 31(8):1688-706. PubMed ID: 19808128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi.
    Anadolu RY; Sen T; Tarimci N; Birol A; Erdem C
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):416-21. PubMed ID: 15196153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of bedoradrine sulfate (MN-221), a novel, highly selective beta2-adrenergic receptor agonist for the treatment of asthma via intravenous infusion.
    Matsuda K; Makhay M; Johnson K; Iwaki Y
    J Asthma; 2012 Dec; 49(10):1071-8. PubMed ID: 23094708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women.
    Hämmerle SP; Mindeholm L; Launonen A; Kiese B; Loeffler R; Harfst E; Azria M; Arnold M; John MR
    Bone; 2012 Apr; 50(4):965-73. PubMed ID: 22289659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy.
    Arpornwirat W; Albert I; Hansen VL; Levin J; Bandekar RR; Grunberg SM
    Cancer; 2009 Dec; 115(24):5807-16. PubMed ID: 19834961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis.
    Cevher E; Açma A; Sinani G; Aksu B; Zloh M; Mülazımoğlu L
    Int J Biol Macromol; 2014 Aug; 69():124-36. PubMed ID: 24857873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and tolerability of single intravenous doses of lubeluzole (Prosynap) in healthy volunteers.
    Hantson L; Tritsmans L; Crabbé R; Gheuens J; Van Rooy P
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):491-5. PubMed ID: 9401829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
    Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of sulfobutyl ether beta-cyclodextrin on DY-9760e-induced cellular damage: In vitro and in vivo studies.
    Nagase Y; Arima H; Wada K; Sugawara T; Satoh H; Hirayama F; Uekama K
    J Pharm Sci; 2003 Dec; 92(12):2466-74. PubMed ID: 14603492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.